Galanin receptor 2 mediates antifibrogenic effects of galanin on hepatic stellate cells

He,Lingnan; Li,Zhenghong; Zhou,Da; Ding,Yongnian; Xu,Leiming; Chen,Yuanwen; Fan,Jiangao

doi:10.3892/etm.2016.3764

Galanin receptor 2 mediates antifibrogenic effects of galanin on hepatic stellate cells

Authors:
- Lingnan He
- Zhenghong Li
- Da Zhou
- Yongnian Ding
- Leiming Xu
- Yuanwen Chen
- Jiangao Fan
View Affiliations

Affiliations: Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China, Department of Gastroenterology, Second Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830028, P.R. China
Published online on: October 3, 2016 https://doi.org/10.3892/etm.2016.3764
Pages: 3375-3380

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Galanin is an endogenous factor involved in the negative regulation of the biological effects of leptin in bioenergetic metabolism. Leptin promotes fibrogenic effects in hepatic stellate cells (HSCs), however, little is known about the effects of galanin on HSCs. In the present study, the biological functions of galanin and its receptors (GalRs) in HSCs were investigated using cell culture in vitro. It was found that galanin and GalR3 mRNA are expressed in quiescent and activated HSCs. GalR2 expression was undetectable in quiescent HSCs but was markedly induced in activated HSCs. In the HSC‑T6 cell line, which is an activated rat HSC cell line, treatment with 100 nmol/l galanin significantly inhibited cell proliferation. It also inhibited transforming growth factor (TGF)‑β1 and α‑smooth muscle actin (SMA) expression and upregulated peroxisome proliferator‑activated receptor (PPAR)‑γ expression. Following the knockdown of GalR2 by specific small interfering RNA, the activation of GalR3 by galanin does not influence these effects of galanin on HSCs. However, activation of GalR2 alone by galanin following the knockdown of GalR3 inhibits HSC proliferation and TGF‑β1 and α‑SMA expression, in addition to inducing PPAR‑γ expression. These data suggest that galanin inhibits HSC activation and suppresses the profibrogenic features of these cells, and these effects might be mediated by GalR2. Thus, galanin is a potential endogenous factor in the inhibition of liver fibrosis.

View Figures

View References

1	Tatemoto K, Rökaeus A, Jörnvall H, McDonald TJ and Mutt V: Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett. 164:124–128. 1983. View Article : Google Scholar : PubMed/NCBI
2	Gundlach AL, Burazin TC and Larm JA: Distribution, regulation and role of hypothalamic galanin systems: Renewed interest in a pleiotropic peptide family. Clin Exp Pharmacol Physiol. 28:100–105. 2001. View Article : Google Scholar : PubMed/NCBI
3	Poritsanos NJ, Mizuno TM, Lautatzis ME and Vrontakis M: Chronic increase of circulating galanin levels induces obesity and marked alterations in lipid metabolism similar to metabolic syndrome. Int J Obes (Lond). 33:1381–1389. 2009. View Article : Google Scholar : PubMed/NCBI
4	Barrachina MD, Martínez V, Wei JY and Taché Y: Leptin-induced decrease in food intake is not associated with changes in gastric emptying in lean mice. Am J Physiol. 272:R1007–R1011. 1997.PubMed/NCBI
5	Li RY, Song HD, Shi WJ, Hu SM, Yang YS, Tang JF, Chen MD and Chen JL: Galanin inhibits leptin expression and secretion in rat adipose tissue and 3T3-L1 adipocytes. J Mol Endocrinol. 33:11–19. 2004. View Article : Google Scholar : PubMed/NCBI
6	Wang J, Leclercq I, Brymora JM, Xu N, Ramezani-Moghadam M, London RM, Brigstock D and George J: Kupffer cells mediate leptin-induced liver fibrosis. Gastroenterology. 137:713–723. 2009. View Article : Google Scholar : PubMed/NCBI
7	Saxena NK, Saliba G, Floyd JJ and Anania FA: Leptin induces increased alpha2(I) collagen gene expression in cultured rat hepatic stellate cells. J Cell Biochem. 89:311–320. 2003. View Article : Google Scholar : PubMed/NCBI
8	Dooley S, Delvoux B, Streckert M, Bonzel L, Stopa M, ten Dijke P and Gressner AM: Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett. 502:4–10. 2001. View Article : Google Scholar : PubMed/NCBI
9	Vogel S, Piantedosi R, Frank J, Lalazar A, Rockey DC, Friedman SL and Blaner WS: An immortalized rat liver stellate cell line (HSC-T6): A new cell model for the study of retinoid metabolism in vitro. J Lipid Res. 41:882–893. 2000.PubMed/NCBI
10	Chen Y, Pat B, Zheng J, Cain L, Powell P, Shi K, Sabri A, Husain A and Dell'italia LJ: Tumor necrosis factor-alpha produced in cardiomyocytes mediates a predominant myocardial inflammatory response to stretch in early volume overload. J Mol Cell Cardiol. 49:70–78. 2010. View Article : Google Scholar : PubMed/NCBI
11	Benyon RC and Arthur MJ: Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis. 21:373–384. 2001. View Article : Google Scholar : PubMed/NCBI
12	Tofighi R, Joseph B, Xia S, Xu ZQ, Hamberger B, Hökfelt T and Ceccatelli S: Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2). Proc Natl Acad Sci USA. 105:2717–2722. 2008. View Article : Google Scholar : PubMed/NCBI
13	Rhaleb NE, Peng H, Harding P, Tayeh M, LaPointe MC and Carretero OA: Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts. Hypertension. 37:827–832. 2001. View Article : Google Scholar : PubMed/NCBI
14	Inagaki Y and Okazaki I: Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut. 56:284–292. 2007. View Article : Google Scholar : PubMed/NCBI
15	Breitkopf K, Godoy P, Ciuclan L, Singer MV and Dooley S: TGF-beta/Smad signaling in the injured liver. Z Gastroenterol. 44:57–66. 2006. View Article : Google Scholar : PubMed/NCBI
16	Hazra S, Miyahara T, Rippe RA and Tsukamoto H: PPAR gamma and hepatic stellate cells. Comp Hepatol. 3(Suppl 1): S72004. View Article : Google Scholar : PubMed/NCBI
17	Tsukamoto H, She H, Hazra S, Cheng J and Miyahara T: Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation. J Gastroenterol Hepatol. 21(Suppl 3): S102–S105. 2006. View Article : Google Scholar : PubMed/NCBI
18	She H, Xiong S, Hazra S and Tsukamoto H: Adipogenic transcriptional regulation of hepatic stellate cells. J Biol Chem. 280:4959–4967. 2005. View Article : Google Scholar : PubMed/NCBI
19	Fathi Z, Battaglino PM, Iben LG, Li H, Baker E, Zhang D, McGovern R, Mahle CD, Sutherland GR, Iismaa TP, et al: Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor. Brain Res Mol Brain Res. 58:156–169. 1998. View Article : Google Scholar : PubMed/NCBI
20	Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, Sundseth SS, Winegar DA, Blanchard DE, Spencer TA and Willson TM: Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem. 272:3137–3140. 1997. View Article : Google Scholar : PubMed/NCBI
21	Wang S, Hashemi T, Fried S, Clemmons AL and Hawes BE: Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes. Biochemistry. 37:6711–6717. 1998. View Article : Google Scholar : PubMed/NCBI
22	Wong L, Yamasaki G, Johnson RJ and Friedman SL: Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest. 94:1563–1569. 1994. View Article : Google Scholar : PubMed/NCBI
23	Kelly JD, Haldeman BA, Grant FJ, Murray MJ, Seifert RA, Bowen-Pope DF, Cooper JA and Kazlauskas A: Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation. J Biol Chem. 266:8987–8992. 1991.PubMed/NCBI